Catheter Precision Profit Margin

The latest profit margin for RMED is -975.3% as of June 2026. That compares with 6549.26% in the prior-year period — down 114.9% year over year. That is below the Healthcare sector average of 13.71%. Investors often review this figure alongside Catheter Precision's historical trend and sector peers before judging valuation or financial health.

Over the past year, RMED's profit margin moved from 6549.26% to -975.3% — a 114.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Catheter Precision's valuation or profitability profile.

Against Healthcare companies, RMED currently prints -975.3% for profit margin, while the sector average sits near 13.71%. That is roughly 7213.4% below the sector mean. Large gaps often invite a closer look at Catheter Precision's growth, margins, and balance sheet.

Profit Margin shows how effectively Catheter Precision converts resources into returns. At -975.3%, RMED may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6549.26% in the prior-year period — down 114.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RMED's profit margin (-975.3%), review year-over-year change from 6549.26%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.